miRNA identified that plays role in milk allergy

miRNA identified that plays role in milk allergy

(HealthDay)—MiR-193a-5p is a post-transcriptional regulator of interleukin-4 (IL-4) expression and could have a role in children's cow's milk allergy (CMA), according to a study published online Aug. 30 in Allergy.

Valeria D'Argenio, M.D., from the University of Naples Federico II in Italy, and colleagues collected peripheral blood mononuclear cells from children aged 4 to 18 months, including 10 CMA patients, nine CMA patients who outgrew CMA, and 11 healthy controls. Next-generation sequencing was used to create small RNA libraries, as well as a functional assessment of IL-4 .

The researchers found that among the micro RNAs (miRNAs) differently expressed, two were up-regulated and 14 were down-regulated in children with active CMA versus healthy controls. In children with active CMA, miR-193a-5p was the most down-regulated miRNA, compared to healthy controls. The predicted targets of miR-193a-5p were up-regulated in CMA patients. A significant up-regulation of IL-4 mRNA and its occurred when peripheral blood CD4+ T cells were transfected with a miR193a-5 inhibitor. Levels of miRNA-193a-5p and expression of its related targets in who outgrew CMA were similar to that seen in healthy controls.

"This miRNA could be a novel diagnostic and therapeutic target for this common form of food allergy in childhood," the authors write.


Explore further

MicroRNA biomarker signature identified for allergic asthma

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Allergy

Copyright © 2017 HealthDay. All rights reserved.

Citation: miRNA identified that plays role in milk allergy (2017, September 13) retrieved 13 November 2019 from https://medicalxpress.com/news/2017-09-mirna-role-allergy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
17 shares

Feedback to editors

User comments